| Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial SP Costello, PA Hughes, O Waters, RV Bryant, AD Vincent, P Blatchford, ... Jama 321 (2), 156-164, 2019 | 768 | 2019 |
| International consensus conference on stool banking for faecal microbiota transplantation in clinical practice G Cammarota, G Ianiro, CR Kelly, BH Mullish, JR Allegretti, Z Kassam, ... Gut 68 (12), 2111-2121, 2019 | 418 | 2019 |
| Systematic review with meta‐analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis SP Costello, W Soo, RV Bryant, V Jairath, AL Hart, JM Andrews Alimentary pharmacology & therapeutics 46 (3), 213-224, 2017 | 298 | 2017 |
| Faecal microbiota transplant for recurrent Clostridium difficile infection using long‐term frozen stool is effective: clinical efficacy and bacterial viability data SP Costello, MA Conlon, MS Vuaran, IC Roberts‐Thomson, JM Andrews Alimentary pharmacology & therapeutics 42 (8), 1011-1018, 2015 | 165 | 2015 |
| Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel G Ianiro, BH Mullish, CR Kelly, H Sokol, Z Kassam, SC Ng, M Fischer, ... The lancet Gastroenterology & hepatology 5 (5), 430-432, 2020 | 159 | 2020 |
| Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic G Ianiro, BH Mullish, CR Kelly, Z Kassam, EJ Kuijper, SC Ng, TH Iqbal, ... Gut 69 (9), 1555-1563, 2020 | 154 | 2020 |
| Bacterial viability in faecal transplants: which bacteria survive? LE Papanicolas, JM Choo, Y Wang, LEX Leong, SP Costello, DL Gordon, ... EBioMedicine 41, 509-516, 2019 | 125 | 2019 |
| Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection SP Costello, EC Tucker, J La Brooy, MN Schoeman, JM Andrews Clinical Infectious Diseases 62 (7), 908-914, 2016 | 125 | 2016 |
| Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice C Haifer, CR Kelly, S Paramsothy, D Andresen, LE Papanicolas, ... Gut 69 (5), 801-810, 2020 | 75 | 2020 |
| Obesity in inflammatory bowel disease: gains in adiposity despite high prevalence of myopenia and osteopenia RV Bryant, CG Schultz, S Ooi, C Goess, SP Costello, AD Vincent, ... Nutrients 10 (9), 1192, 2018 | 72 | 2018 |
| Deficient resident memory T cell and CD8 T cell response to commensals in inflammatory bowel disease A Noble, L Durant, L Hoyles, AL McCartney, R Man, J Segal, SP Costello, ... Journal of Crohn's and Colitis 14 (4), 525-537, 2020 | 70 | 2020 |
| Adjunctive fecal microbiota transplantation in supportive oncology: Emerging indications and considerations in immunocompromised patients HR Wardill, KR Secombe, RV Bryant, MD Hazenberg, SP Costello EBioMedicine 44, 730-740, 2019 | 64 | 2019 |
| Short duration, low intensity, pooled fecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial SP Costello, O Waters, RV Bryant, R Katsikeros, J Makanyanga, ... Gastroenterology 152 (5), S198-S199, 2017 | 59 | 2017 |
| Visceral adipose tissue is associated with stricturing Crohn’s disease behavior, fecal calprotectin, and quality of life RV Bryant, CG Schultz, S Ooi, C Goess, SP Costello, AD Vincent, ... Inflammatory bowel diseases 25 (3), 592-600, 2019 | 57 | 2019 |
| Food avoidance, restrictive eating behaviour and association with quality of life in adults with inflammatory bowel disease: a systematic scoping review AS Day, CK Yao, SP Costello, JM Andrews, RV Bryant Appetite 167, 105650, 2021 | 55 | 2021 |
| Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial S Costello, O Waters, R Bryant, R Katsikeros, J Makanyanga, ... Journal of Crohn's and Colitis 11 (S1), S23-S23, 2017 | 52 | 2017 |
| Limited uptake of ulcerative colitis “treat‐to‐target” recommendations in real‐world practice RV Bryant, SP Costello, S Schoeman, D Sathananthan, E Knight, SY Lau, ... Journal of gastroenterology and hepatology 33 (3), 599-607, 2018 | 49 | 2018 |
| the future of microbiome‐based therapeutics EL Gulliver, RB Young, M Chonwerawong, GL D'Adamo, T Thomason, ... Alimentary Pharmacology & Therapeutics 56 (2), 192-208, 2022 | 44 | 2022 |
| Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease‐related knowledge A Rajagopalan, D Sathananthan, YK An, L Van De Ven, S Martin, J Fon, ... JGH Open 4 (2), 267-272, 2020 | 42 | 2020 |
| The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease LR Lopetuso, S Deleu, L Godny, V Petito, P Puca, F Facciotti, H Sokol, ... Gut 72 (9), 1642-1650, 2023 | 41 | 2023 |
Robert Venning BryantHead of Inflammatory Bowel Service The Queen Elizabeth HospitalVerified email at adelaidegastroconsultants.com.au
